X0306 4 2014-06-25 0 0001510580 Kite Pharma, Inc. KITE 0001198321 CHAMPSI FARAH C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404 1 0 0 0 Common Stock 2014-06-25 4 C 0 2166889 A 2166889 I See Footnote Common Stock 2014-06-25 4 J 0 759170 15.30 A 2926059 I See Footnote Series A Convertible Preferred Stock 2014-06-25 4 C 0 2158545 0.00 D Common Stock 2166889 0 I See Footnote Includes 8,344 shares issued in payment of accrued dividends. The Series A Convertible Preferred Stock converted on a 1-for-1 basis and had no expiration date. The securities are held of record by Alta Partners VIII, L.P. ("APVIII"). Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. The reporting person is a managing director of APMVIII and exercises shared voting and investment power with respect to the shares owned by APVIII. The reporting person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein. Automatic conversion, in connection with the Issuer's initial public offering, of convertible promissory notes, including principal and accrued interest. /s/ David Tanen, Attorney-in-Fact 2014-06-27